Connor, Clark & Lunn Investment Management (CC&L)’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.86M | Buy |
248,859
+134,649
| +118% | +$4.25M | 0.03% | 458 |
|
|
2025
Q1 | $3.79M | Buy |
+114,210
| New | +$3.79M | 0.02% | 574 |
|
|
2024
Q4 | – | Sell |
-8,974
| Closed | -$359K | – | 1497 |
|
|
2024
Q3 | $359K | Buy |
+8,974
| New | +$359K | ﹤0.01% | 1188 |
|
|
2023
Q4 | – | Sell |
-8,742
| Closed | -$286K | – | 1462 |
|
|
2023
Q3 | $286K | Buy |
+8,742
| New | +$286K | ﹤0.01% | 1155 |
|